Week 4- Liability for defective goods and premises Flashcards
What is the general premise of the Consumer protection act 1987 with regards to defective products?
What is the first limitation on what can be claimed as damage deriving from defectives products?
- This is once again a negligence-like tort, deriving from the case of Donoghue and Stephenson, concerned with the negligence of a drinks manufacturer who owed a duty of care to her ‘neighbour’ to prevent personal injury- someone with a direct relationship to the defendant which could be described as ‘proximate’ (not necessarily physical proximity was required).
- The consumer protection act 1987 increases the extent of liability on the part of the manufacturers, where a defect of their product causes damage. It only extends to consequential damage much like negligence, but no liability for damages by reference to the purchase price or value of the product, or damage done to the product itself. Liability is referred to under the act without any reference to fault on Ds behalf. There is no requirement that fault be established for the producer.
- The act does not dictate liability is established for all injury or damage caused by a product; there must be a defect in the product. This differs to common law negligence in that negligence would be in relation to design, manufacture or marketing of the product, whilst this tort is concerned with an actual defect of product. There may be negligence without defect in the product, but this would not fall under the Consumer protection act 1987.
What does the CPA dictate the meaning of ‘producer’ to be?
What is a ‘product’ defined as?
(a) the person who manufactured it;
(b) in the case of a substance which has not been manufactured but has been won or abstracted, the person who won or abstracted it;
(c) in the case of a product which has not been manufactured, won or abstracted but essential characteristics of which are attributable to an industrial or other process having been carried out (for example, in relation to agricultural produce), the person who carried out that process;
“product” means any goods or electricity and (subject to subsection (3) below) includes a product which is comprised in another product, whether by virtue of being a component part or raw material or otherwise
What does the EU directive on liability for defective products say?
-The EU product liability directive has dictated that product manufacturers take the risks of defectiveness, whether these risks are produced by lack of care or not, whilst consumers take the risks associated with non-defective products (subject to liability for contract and tort).
What is the main defence under the CPA 1987?
Development risks defence
-The main defence is that a manufacturer would not be liable for subsequent damage sustained by a consumer from a defective product where the scientific knowledge at the time of production does not allow for the defect to be discovered by the producer.
Who can be liable as a producer under s2 of the CPA?
For what are they liable for under the statute?
2 Liability for defective products
(1) Subject to the following provisions of this Part, where any damage is caused wholly or partly by a defect in a product, every person to whom subsection (2) below applies shall be liable for the damage.
(2) This subsection applies to—
(a) the producer of the product;
(b) any person who, by putting his name on the product or using a trade-mark or other distinguishing mark in relation to the product, has held himself out to be the producer of the product;
(c) any person who has imported the product into a member State from a place outside the member States in order, in the course of any business of his, to supply it to another.
What is a product as per the CPA? what limitations are there with regards to components?
1(2)(c) ”product” means any goods or electricity and (subject to subsection (3) below) includes a product which is comprised in another product, whether by virtue of being a component part or raw material or otherwise; … By section 2(3) (above), faulty component parts are treated as being separate products, and the party who is potentially liable if those components are defective is the producer (or importer, and so on) of those components, rather than of the product in which they are incorporated. However, the manufacturer of a component part will not be liable for damage done to the larger product in which it is incorporated: see section 5(2) extracted below, refining the definition of ‘damage’ recoverable under the Act
What damage can a producer be liable for?
What is the monetary limit placed on actionable claims for defective products?
1) Subject to the following provisions of this section, in this Part “damage” means death or personal injury or any loss of or damage to any property (including land).
(2) A person shall not be liable under section 2 above in respect of any defect in a product for the loss of or any damage to the product itself or for the loss of or any damage to the whole or any part of any product which has been supplied with the product in question comprised in it.
(4) No damages shall be awarded to any person by virtue of this Part in respect of any loss of or damage to any property if the amount which would fall to be so awarded to that person, apart from this subsection and any liability for interest, does not exceed £275. (avoids litigation for trifling property damage)
Overview of the CPA and its comparison to negligence regarding actionable damage and statutory limitations on recoverability?
The damages recoverable under the CPA are similar to those in negligence, and the damage must be to the person (death or personal injury) or to other property including land (but excluding damage to the defective product).
-Component parts are their own individual products, and it does not suffice that this component causes damage to product in which it is incorporated into.
-£275 minimum damage claim must be reached
Finally, damage to property not intended for private or family use (eg commercial property) is not recoverable under the act
what is the meaning of ‘defectiveness’ as per the CPA? What is the general standard of product?
1) Subject to the following provisions of this section, there is a defect in a product for the purposes of this Part if the safety of the product is not such as persons generally are entitled to expect; and for those purposes “safety”, in relation to a product, shall include safety with respect to products comprised in that product and safety in the context of risks of damage to property, as well as in the context of risks of death or personal injury.
The key question with regard to defects is whether the safety of the product is not such as persons generally are entitled to expect, with all the circumstances being taken into account. These may include the purposes and manner in which the product has been marketed, instructions, warnings, the time that the product was supplied.
facts and significance of Tesco Stores v Connor Frederick Pollock 2006? Regarding understanding of defectiveness under CPA 1987?
Facts- the claimant was a 13-month old child who had swallowed dishwasher powder from a plastic bottle bought from Tesco, causing him to become seriously ill. The bottle was meant to have a “child resistant cap” yet the one year old managed to open it. Evidence showed the cap was far too easy to open compared to what was expected under British standards, although conversely it required much more force than was reasonably expected from a 13-month-old child. The question was, in the absence of a legal requirement for a child-proof cap, whether the product could be described as defective under the Consumer products act, and therefore if it provided the level of safety that persons generally would be entitled to expect of this product.
Significance- the action failed, and the product was deemed not to be defective.
- Laws LJ “What, on the facts here, were ‘persons generally entitled to expect’ of the safety features of this cap and bottle? In my judgment they were entitled to expect that the bottle would be more difficult to open than if it had an ordinary screwtop. Anything more specific, as a test of public expectation, runs into the difficulties which I have just described. Here, the bottle was more difficult to open than an ordinary screwtop, though not as difficult to open as it would have been if the British Standard torque measure had been complied with. There was, in my judgment, no breach of the 1987 Act.”
- Some might argue that some more specificity was required as to what the reasonable person could be entitled to expect from the bottle cap. Surely it merely required that any extra resistance required to open the cap compared to a normal cap would suffice for deeming the product not defective. Conversely, the resistance of the cap may be in the range of reasonable expectations of the product, even if towards the lower end of the spectrum of reasonable expectations which consumers are entitled to hold with regards to this product. Either way, for the purposes of the CPA, the screw top bottle could not be described as defective.
A v National blood authority and another 2001 facts and significance?
Facts- All claimants had contracted Hepatitis from blood transfusions, and the actions were brought against the suppliers of the relevant blood products. At the time of the transfusions, the medical professions and the defendants were aware of the risk of Hepatitis C infection, but this knowledge was not shared with the general public. There was an ‘actual expectation’ of clean blood, but this was not the same as what the public was entitled to expect from a product, owing to their own lack of scientific knowledge of the risks. There was no test available to test the blood being used for the transfusion, so the risk of infection was unavoidable and not negligent. The only action that could be brought was under the CPA.
Significance- The question was whether or not the blood products were defective, even where it was unavoidable that some would be infected by Hepatitis C. It was held that they were defective, and the ‘development risks defence’ did not apply, as there was no way to find out which blood was infected.
- The binding judgement of the ECJ meant that, whilst the CPA had not incorporated the express words of the ECC directive, the judge construed the CPA with reference to the meaning of the ECC directive instead (whilst other cases decline to bypass the wording of the CPA) (Burton J)
- The blood was decided to be defective for the following reasons:
1) The general public were unaware of the risk, even though the medical professionals were aware of the risk; the public were therefore entitled to expect clean blood based off of their own knowledge, even though the professionals knew it could be unattainable. Even though the blood supplied was no worse than any other blood which was supplied, the knowledge of the general public meant they were entitled to expect a higher quality than what they received; they were entitled to expect safe blood, but this was not supplied, and it was impossible for anything else to be supplied.
2) Unavoidability was irrelevant to the safety of the product; the fact that something is unavoidable will not afford a defence for the defendant, and it was not relevant for the test for defectiveness. The considerations in s3(2) affect the safety of the product and are to be considered eg who is going to use it, how it is likely to be used etc. Unavoidability has no place here.
3) The bags were non-standard. Whilst some products eg alcohol or tobacco are inherently risky, they carry the same risk, and it is up to the claimant’s individual characteristics or use as to how far this risk materialises. This is accepted by consumers, and so they are not entitled to expect anything from such products other than the potential harm which they may cause. Unlike this, some blood bags were infected, and some weren’t. There was no acceptance of the non-standard nature of the product. Those which weren’t infected were standard bags whilst those which weren’t were not; it did not matter that it was not ascertainable which were standard, and which weren’t. Further to this, inherently risky products inform the consumer of the risks, whilst the risks associated with the blood were not disclosed to the public. The risks associated with standard products of alcohol and tobacco aren’t avoidable, but they are disclosed and the same for all standard products, and therefore cannot be described as ‘defective’. (standard products can have design defects, which some would argue are present in tobacco/ alcohol).
What is the difference between manufacturing defects and design defects?
A manufacturing defect is one which makes the product defective for the purposes of the CPA 1987, because it can be considered as non-standard when compared to how the product is usually made (and therefore what the public at large are entitled to expect from a non-manufacturing defect product). It has not been manufactured to the same level of safety as other products, which is why the public are entitled to expect a higher level of safety than is otherwise provided by this anomaly.
A design defect may still be a standard product, with the public at large accepting the defective design which is inherent in all of the same batch of products eg alcohol or tobacco, where the use and design of the product is inherently risky and dangerous (but the extent of the danger can be determined by many factors outside of the manufacturers control). The public is only entitled to expect a risk to the safety of their own health from tobacco or alcohol, as this is inherent in the design of the product.
What is the difference between standard and non-standard products?
Non-standard products- products which are not at the standard expected by a producer ie compared to the rest of the same batch of products. Defects which arise in non-standard products are defective because the level of safety that the consumer is entitled to expect is likely to be that which the standard product without the manufacturing defect would provide. Therefore, you run the consumer expectation test, and it is likely that the defendant would be liable for the personal injury or property damage which resulted from this MANUFACTURING DEFECT
-Liability is strict under the CPA, and therefore it does not matter if the manufacturer could not avoid the manufacturing defect. Even if he could, in the case of A he would test all the blood for hepatitis C, and only supply standard products, then he is still liable unless all the standard products were not defective. The risk was unavoidable, and they were still liable.
Standard products: Standard products are a group of products which are all of the same quality and level of safety; the standard likely to be expected by the consumer, as they are entitled to expect this. Standard products may still be defective, as a result of a design defect, if they are inherently ‘unsafe’. Instead of running the consumer safety test, the avoidability test is incorporated into a risk-utility test. Was the cost of avoiding the defect, combined with the risk of the design defect so great as to outweigh the current benefits associated with the product? If the utility gained is higher than the risks and costs of failing to change the design, then there is no defect. This is a matter for the courts.
What is the development risks defence for producers?
The development risks defence:
-The producer only takes the risks of defects that could have been discovered at the relevant time, otherwise a latent defect which could not be ascertained at the point of supply is a risk which falls upon the consumer. The key element is the ‘apportionment of risk’, as noted in the preamble to the EU directive 85/374/EEC:
“Whereas liability without fault on the part of the producer is the sole means of adequately solving the problem, peculiar to our age of increasing technicality, of a fair apportionment of the risks inherent in modern technological production;
…
Whereas a fair apportionment of risk between the injured person and the producer implies that the producer should be able to free himself from liability if he furnishes proof that as to the existence of certain exonerating circumstances…”
It is suggested that the reason for this defence is to avoid the ‘deterrence of beneficial risk-creation’, in that they do not want to discourage innovation and stifle productive risks. Any issues with this defence may be further exacerbated by the UKs treatment of the directive, and the way in which they have ‘apportioned this risk’.
What does the textbook suggest are the two main criticisms of the UK’s integration of the risk apportionment EU directive (recognising a defect)?
- There is claimed to be a substantial difference between what a producer might be expected to discover, as in the Act; and what it would be possible to discover, given the existing state of knowledge, as in the Directive. It is argued by some that the former sets a standard of reasonable expectation, and is therefore quite similar to negligence. (p. 867)
- The UK wording seems to suggest that the relevant knowledge (when judging whether it would have been possible to recognize the defect) is knowledge of producers in the industry. The wording in the Directive seems to encompass scientific knowledge wherever it was being developed, rather than industry wide, making it a much more strict defence than the defence which the CPA seems to be incorporating.
There has been some support for the UK’s interpretation of the development risks defence. For example Christopher Newdick suggested at the time of enactment that the version adopted by the UK simply expressed more clearly what would be the inevitable content of the test.”
- The UK wording seems to suggest that the relevant knowledge (when judging whether it would have been possible to recognize the defect) is knowledge of producers in the industry. The wording in the Directive seems to encompass scientific knowledge wherever it was being developed, rather than industry wide, making it a much more strict defence than the defence which the CPA seems to be incorporating.